Your browser doesn't support javascript.
loading
Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
Lee, John D; Liu, Ning; Levin, Samantha C; Ottosson, Lars; Andersson, Ulf; Harris, Helena E; Woodruff, Trent M.
Affiliation
  • Lee JD; Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
  • Liu N; Faculty of Medicine, University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, QLD, 4029, Australia.
  • Levin SC; Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
  • Ottosson L; Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.
  • Andersson U; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Harris HE; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Woodruff TM; Centre for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
J Neuroinflammation ; 16(1): 45, 2019 Feb 19.
Article in En | MEDLINE | ID: mdl-30782181
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HMGB1 Protein / Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2019 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HMGB1 Protein / Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2019 Type: Article Affiliation country: Australia